Jennifer Burstein - Net Worth and Insider Trading
Jennifer Burstein Net Worth
The estimated net worth of Jennifer Burstein is at least $0 dollars as of 2024-12-26. Jennifer Burstein is the Senior VP of Finance of Loxo Oncology Inc and owns about 0 shares of Loxo Oncology Inc (LOXO) stock worth over $0. Details can be seen in Jennifer Burstein's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jennifer Burstein has not made any transactions after 2018-12-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jennifer Burstein
Jennifer Burstein Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jennifer Burstein owns 2 companies in total, including Stoke Therapeutics Inc (STOK) , and Loxo Oncology Inc (LOXO) .
Click here to see the complete history of Jennifer Burstein’s form 4 insider trades.
Insider Ownership Summary of Jennifer Burstein
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| STOK | Stoke Therapeutics Inc | 2020-06-03 | director |
| LOXO | Loxo Oncology Inc | 2019-02-15 | Senior VP of Finance |
Jennifer Burstein Latest Holdings Summary
Jennifer Burstein currently owns a total of 1 stock. Jennifer Burstein owns 0 shares of Loxo Oncology Inc (LOXO) as of December 11, 2018, with a value of $0.
Latest Holdings of Jennifer Burstein
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LOXO | Loxo Oncology Inc | 2018-12-11 | 0 | 234.66 | 0 |
Holding Weightings of Jennifer Burstein
Jennifer Burstein Form 4 Trading Tracker
According to the SEC Form 4 filings, Jennifer Burstein has made a total of 0 transactions in Loxo Oncology Inc (LOXO) over the past 5 years. The most-recent trade in Loxo Oncology Inc is the sale of 2,500 shares on December 11, 2018, which brought Jennifer Burstein around $338,875.
Insider Trading History of Jennifer Burstein
- 1
Jennifer Burstein Trading Performance
Jennifer Burstein Ownership Network
Jennifer Burstein Owned Company Details
What does Stoke Therapeutics Inc do?
Who are the key executives at Stoke Therapeutics Inc?
Jennifer Burstein is the director of Stoke Therapeutics Inc. Other key executives at Stoke Therapeutics Inc include General Counsel & Corp Sec Jonathan Allan , director & CEO Kaye Edward M. Md , and Chief Medical Officer Barry Ticho .
Stoke Therapeutics Inc (STOK) Insider Trades Summary
Over the past 18 months, Jennifer Burstein made no insider transaction in Stoke Therapeutics Inc (STOK). Other recent insider transactions involving Stoke Therapeutics Inc (STOK) include a net sale of 145,647 shares made by Barry Ticho , a net sale of 39,436 shares made by Jonathan Allan , and a net sale of 66,456 shares made by Kaye Edward M. Md .
In summary, during the past 3 months, insiders sold 82,849 shares of Stoke Therapeutics Inc (STOK) in total and bought 0 shares, with a net sale of 82,849 shares. During the past 18 months, 5,849,771 shares of Stoke Therapeutics Inc (STOK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 5,849,771 shares.
Stoke Therapeutics Inc (STOK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Stoke Therapeutics Inc Insider Transactions
Jennifer Burstein Mailing Address
Above is the net worth, insider trading, and ownership report for Jennifer Burstein. You might contact Jennifer Burstein via mailing address: C/o Loxo Oncology, Inc., One Landmark Square, Suite 1122, Stamford Ct 06901.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
